New knee injection polymer put to the test in first human trial
Symptom relief
Not yet recruiting
This early study tests the safety of a single injection of a new polymer called ABR1 for knee osteoarthritis. About 25 adults with moderate to severe knee pain will receive the injection and be followed for 12 weeks. The main goal is to see if the treatment causes any side effect…
Phase: NA • Sponsor: Pleryon Therapeutics (Hangzhou) Limited • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC